Bates ER. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375:2605.
Byrne RA, Stone GW, Ormiston J, Kastrati A. Coronary balloon angioplasty, stents, and scaffolds. Lancet. 2017;390:781–92.
Mintz GS, Guagliumi G. Intravascular imaging in coronary artery disease. Lancet. 2017;390:793–809.
The L. 40 years of percutaneous coronary intervention: Where next? Lancet. 2017;390:715.
Mills B, Robb T, Larson DF. Intimal hyperplasia: slow but deadly. Perfusion. 2012;27:520–8.
Article CAS PubMed Google Scholar
Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest. 2012;122:787–95.
Article CAS PubMed PubMed Central Google Scholar
Varin A, Gordon S. Alternative activation of macrophages: Immune function and cellular biology. Immunobiology. 2009;214:630–41.
Article CAS PubMed Google Scholar
Nahrendorf M, Swirski FK. Abandoning m1/m2 for a network model of macrophage function. Circ Res. 2016;119:414–7.
Article CAS PubMed PubMed Central Google Scholar
Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017;79:541–66.
Article CAS PubMed Google Scholar
Inoue J, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S, Yamamoto T. Tumor necrosis factor receptor-associated factor (traf) family: adapter proteins that mediate cytokine signaling. Exp Cell Res. 2000;254:14–24.
Article CAS PubMed Google Scholar
Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (trafs). Oncogene. 2001;20:6482–91.
Article CAS PubMed Google Scholar
Miyahara T, Koyama H, Miyata T, Shigematsu H, Inoue J, Takato T, Nagawa H. Inflammatory signaling pathway containing traf6 contributes to neointimal formation via diverse mechanisms. Cardiovasc Res. 2004;64:154–64.
Article CAS PubMed Google Scholar
Miyahara T, Koyama H, Miyata T, Shigematsu H, Inoue J, Takato T, Nagawa H. Inflammatory responses involving tumor necrosis factor receptor-associated factor 6 contribute to in-stent lesion formation in a stent implantation model of rabbit carotid artery. J Vasc Surg. 2006;43:592–600.
Missiou A, Rudolf P, Stachon P, Wolf D, Varo N, Aichele P, Colberg C, Hoppe N, Ernst S, Munkel C, Walter C, Sommer B, Hilgendorf I, Nakano H, Bode C, Zirlik A. Traf5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Circ Res. 2010;107:757–66.
Article CAS PubMed Google Scholar
Hildebrand JM, Yi Z, Buchta CM, Poovassery J, Stunz LL, Bishop GA. Roles of tumor necrosis factor receptor associated factor 3 (traf3) and traf5 in immune cell functions. Immunol Rev. 2011;244:55–74.
Article CAS PubMed PubMed Central Google Scholar
Wang PX, Zhang XJ, Luo P, Jiang X, Zhang P, Guo J, Zhao GN, Zhu X, Zhang Y, Yang S, Li H. Hepatocyte traf3 promotes liver steatosis and systemic insulin resistance through targeting tak1-dependent signalling. Nat Commun. 2016;7:10592.
Article CAS PubMed PubMed Central Google Scholar
Missiou A, Kostlin N, Varo N, Rudolf P, Aichele P, Ernst S, Munkel C, Walter C, Stachon P, Sommer B, Pfeifer D, Zirlik K, MacFarlane L, Wolf D, Tsitsikov E, Bode C, Libby P, Zirlik A. Tumor necrosis factor receptor-associated factor 1 (traf1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation. 2010;121:2033–44.
Article CAS PubMed PubMed Central Google Scholar
Ruspi G, Schmidt EM, McCann F, Feldmann M, Williams RO, Stoop AA, Dean JL. Tnfr2 increases the sensitivity of ligand-induced activation of the p38 mapk and nf-kappab pathways and signals traf2 protein degradation in macrophages. Cell Signal. 2014;26:683–90.
Article CAS PubMed Google Scholar
Das A, Sudhahar V, Ushio-Fukai M, Fukai T. Novel interaction of antioxidant-1 with traf4: role in inflammatory responses in endothelial cells. Am J Physiol Cell Physiol. 2019;317:C1161–71.
Article CAS PubMed PubMed Central Google Scholar
Wang L, Lu Y, Guan H, Jiang D, Guan Y, Zhang X, Nakano H, Zhou Y, Zhang Y, Yang L, Li H. Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction. J Neurochem. 2013;126:400–14.
Article CAS PubMed Google Scholar
Gao L, Wang PX, Zhang Y, Yu CJ, Ji Y, Wang X, Zhang P, Jiang X, Jin H, Huang Z, Zhang ZR, Li H. Tumor necrosis factor receptor-associated factor 5 (traf5) acts as an essential negative regulator of hepatic steatosis. J Hepatol. 2016;65:125–36.
Article CAS PubMed Google Scholar
Bian Z, Dai J, Hiroyasu N, Guan H, Yuan Y, Gan L, Zhou H, Zong J, Zhang Y, Li F, Yan L, Shen D, Li H, Tang Q. Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis. J Cell Biochem. 2014;115:349–58.
Article CAS PubMed Google Scholar
Xu W, Zhang L, Ma S, Zhang Y, Cai Z, Zhang K, Jin D. Traf5 protects against myocardial ischemia reperfusion injury via akt signaling. Eur J Pharmacol. 2020;878: 173092.
Article CAS PubMed Google Scholar
Ob ER, Ma X, Simard T, Pourdjabbar A, Hibbert B. Pathogenesis of neointima formation following vascular injury. Cardiovasc Hematol Disord Drug Targets. 2011;11:30–9.
Rzucidlo EM. Signaling pathways regulating vascular smooth muscle cell differentiation. Vascular. 2009;17(Suppl 1):S15-20.
Davis-Dusenbery BN, Wu C, Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol. 2011;31:2370–7.
Article CAS PubMed PubMed Central Google Scholar
Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv. 2011;4:104–11.
Article CAS PubMed Google Scholar
Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74:13–40.
Article CAS PubMed Google Scholar
Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009;29:1419–23.
Article CAS PubMed Google Scholar
Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, Yeh WC, Nakano H. Critical roles of traf2 and traf5 in tumor necrosis factor-induced nf-kappa b activation and protection from cell death. J Biol Chem. 2001;276:36530–4.
Article CAS PubMed Google Scholar
Nagashima H, Okuyama Y, Asao A, Kawabe T, Yamaki S, Nakano H, Croft M, Ishii N, So T. The adaptor traf5 limits the differentiation of inflammatory cd4(+) t cells by antagonizing signaling via the receptor for il-6. Nat Immunol. 2014;15:449–56.
Article CAS PubMed PubMed Central Google Scholar
Eguchi J, Kong X, Tenta M, Wang X, Kang S, Rosen ED. Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization. Diabetes. 2013;62:3394–403.
Article CAS PubMed PubMed Central Google Scholar
Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S. The jmjd3-irf4 axis regulates m2 macrophage polarization and host responses against helminth infection. Nat Immunol. 2010;11:936–44.
Article CAS PubMed Google Scholar
Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol. 2011;11:750–61.
Article CAS PubMed Google Scholar
Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific ppargamma controls alternative activation and improves insulin resistance. Nature. 2007;447:1116–20.
Article CAS PubMed PubMed Central Google Scholar
Charo IF. Macrophage polarization and insulin resistance: Ppargamma in control. Cell Metab. 2007;6:96–8.
留言 (0)